Table of Content


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.2 Unpaid sources
1.5.3 Primary
Chapter 2 Executive Summary
2.1 Neurovascular devices industry 360 degree synopsis, 2017 – 2030
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Process trends
2.1.4 Therapeutic applications trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Neurovascular Devices Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing number of brain aneurysm and ischemic strokes in North America
3.3.1.2 Rising demand for minimally invasive surgical procedures
3.3.1.3 Technological advancement in neurovascular treatments
3.3.1.4 Government initiatives to modernize healthcare infrastructure across the globe
3.3.2 Industry pitfalls and challenges
3.3.2.1 Need for designing more effective and low-cost treatments
3.3.2.2 Challenges involved in commercialization of neurovascular devices across developing and underdeveloped economies
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By process
3.4.3 By therapeutic applications
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory and reimbursement landscape
3.6.1 U.S.
3.6.2 Europe
3.6.3 China
3.7 Porter’s analysis
3.8 Competitive landscape, 2021
3.8.1 Company matrix analysis, 2021
3.9 PESTEL analysis
Chapter 4 Neurovascular Devices Market, By Product
4.1 Key segment trends
4.2 Embolic coils
4.2.1 Market size, by region, 2017 – 2030 (USD Million)
4.2.2 Market size, by region, 2017 – 2030 (000’ Units)
4.3 Carotid stents
4.3.1 Market size, by region, 2017 – 2030 (USD Million)
4.3.2 Market size, by region, 2017 – 2030 (000’ Units)
4.4 Intracranial stents
4.4.1 Market size, by region, 2017 – 2030 (USD Million)
4.4.2 Market size, by region, 2017 – 2030 (000’ Units)
4.5 Catheters
4.5.1 Market size, by region, 2017 – 2030 (USD Million)
4.5.2 Market size, by region, 2017 – 2030 (000’ Units)
4.6 Embolic protection devices
4.6.1 Market size, by region, 2017 – 2030 (USD Million)
4.6.2 Market size, by region, 2017 – 2030 (000’ Units)
4.7 Flow diverters
4.7.1 Market size, by region, 2017 – 2030 (USD Million)
4.7.2 Market size, by region, 2017 – 2030 (000’ Units)
4.8 Neurothrombectomy devices
4.8.1 Market size, by region, 2017 – 2030 (USD Million)
4.8.2 Market size, by region, 2017 – 2030 (000’ Units)
4.9 Intrasaccular devices
4.9.1 Market size, by region, 2017 – 2030 (USD Million)
4.9.2 Market size, by region, 2017 – 2030 (000’ Units)
4.10 Balloon systems
4.10.1 Market size, by region, 2017 – 2030 (USD Million)
4.10.2 Market size, by region, 2017 – 2030 (000’ Units)
4.11 Stent retrievers
4.11.1 Market size, by region, 2017 – 2030 (USD Million)
4.11.2 Market size, by region, 2017 – 2030 (000’ Units)
4.12 Guidewires
4.12.1 Market size, by region, 2017 – 2030 (USD Million)
4.12.2 Market size, by region, 2017 – 2030 (000’ Units)
4.13 Others
4.13.1 Market size, by region, 2017 – 2030 (USD Million)
4.13.2 Market size, by region, 2017 – 2030 (000’ Units)
Chapter 5 Neurovascular Devices Market, By Process
5.1 Key segment trends
5.2 Neurothrombectomy
5.2.1 Market size, by region, 2017 – 2030 (USD Million)
5.3 Cerebral angiography
5.3.1 Market size, by region, 2017 – 2030 (USD Million)
5.4 Carotid endarterectomy (CEA)
5.4.1 Market size, by region, 2017 – 2030 (USD Million)
5.5 Stenting
5.5.1 Market size, by region, 2017 – 2030 (USD Million)
5.6 Microsurgical clipping
5.6.1 Market size, by region, 2017 – 2030 (USD Million)
5.7 Coiling
5.7.1 Market size, by region, 2017 – 2030 (USD Million)
5.8 Flow diversion
5.8.1 Market size, by region, 2017 – 2030 (USD Million)
5.9 Others
5.9.1 Market size, by region, 2017 – 2030 (USD Million)
Chapter 6 Neurovascular Devices Market, By Therapeutic Applications
6.1 Key segment trends
6.2 Brain aneurysm
6.2.1 Market size, by region, 2017 – 2030 (USD Million)
6.3 Stenosis
6.3.1 Market size, by region, 2017 – 2030 (USD Million)
6.4 Ischemic strokes
6.4.1 Market size, by region, 2017 – 2030 (USD Million)
6.5 Others
6.5.1 Market size, by region, 2017 – 2030 (USD Million)
Chapter 7 Neurovascular Devices Market, By End-use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market size, by region, 2017 – 2030 (USD Million)
7.3 Ambulatory surgical centers
7.3.1 Market size, by region, 2017 – 2030 (USD Million)
7.4 Clinics
7.4.1 Market size, by region, 2017 – 2030 (USD Million)
7.5 Others
7.5.1 Market size, by region, 2017 – 2030 (USD Million)
Chapter 8 Neurovascular Devices Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2017 – 2030 (USD Million)
8.2.2 Market size, by country, 2017 – 2030 (000’ Units)
8.2.3 Market size, by product, 2017 – 2030 (USD Million)
8.2.4 Market size, by product, 2017 – 2030 (000’ Units)
8.2.5 Market size, by process, 2017 – 2030 (USD Million)
8.2.6 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.2.7 Market size, by end-use, 2017 – 2030 (USD Million)
8.2.8 U.S.
8.2.8.1 Market size, by product, 2017 – 2030 (USD Million)
8.2.8.2 Market size, by product, 2017 – 2030 (000’ Units)
8.2.8.3 Market size, by process, 2017 – 2030 (USD Million)
8.2.8.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.2.8.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.2.9 Canada
8.2.9.1 Market size, by product, 2017 – 2030 (USD Million)
8.2.9.2 Market size, by product, 2017 – 2030 (000’ Units)
8.2.9.3 Market size, by process, 2017 – 2030 (USD Million)
8.2.9.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.2.9.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2017 – 2030 (USD Million)
8.3.2 Market size, by country, 2017 – 2030 (000’ Units)
8.3.3 Market size, by product, 2017 – 2030 (USD Million)
8.3.4 Market size, by product, 2017 – 2030 (000’ Units)
8.3.5 Market size, by process, 2017 – 2030 (USD Million)
8.3.6 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.7 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.8 Germany
8.3.8.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.8.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.8.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.8.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.8.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.9 France
8.3.9.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.9.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.9.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.9.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.9.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.10 UK
8.3.10.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.10.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.10.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.10.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.10.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.11 Italy
8.3.11.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.11.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.11.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.11.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.11.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.12 Spain
8.3.12.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.12.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.12.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.12.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.12.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.13 Russia
8.3.13.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.13.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.13.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.13.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.13.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.14 Turkey
8.3.14.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.14.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.14.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.14.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.14.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.15 Netherlands
8.3.15.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.15.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.15.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.15.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.15.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.16 Belgium
8.3.16.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.16.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.16.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.16.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.16.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.17 Austria
8.3.17.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.17.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.17.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.17.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.17.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.18 Switzerland
8.3.18.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.18.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.18.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.18.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.18.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.19 Poland
8.3.19.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.19.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.19.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.19.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.19.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.20 Czech Republic
8.3.20.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.20.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.20.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.20.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.20.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.21 Hungary
8.3.21.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.21.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.21.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.21.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.21.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.22 Portugal
8.3.22.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.22.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.22.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.22.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.22.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.23 Greece
8.3.23.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.23.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.23.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.23.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.23.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.24 Romania
8.3.24.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.24.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.24.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.24.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.24.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.25 Bulgaria
8.3.25.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.25.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.25.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.25.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.25.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.26 Denmark
8.3.26.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.26.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.26.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.26.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.26.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.27 Sweden
8.3.27.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.27.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.27.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.27.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.27.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.28 Norway
8.3.28.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.28.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.28.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.28.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.28.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.3.29 Finland
8.3.29.1 Market size, by product, 2017 – 2030 (USD Million)
8.3.29.2 Market size, by product, 2017 – 2030 (000’ Units)
8.3.29.3 Market size, by process, 2017 – 2030 (USD Million)
8.3.29.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.3.29.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2017 – 2030 (USD Million)
8.4.2 Market size, by country, 2017 – 2030 (000’ Units)
8.4.3 Market size, by product, 2017 – 2030 (USD Million)
8.4.4 Market size, by product, 2017 – 2030 (000’ Units)
8.4.5 Market size, by process, 2017 – 2030 (USD Million)
8.4.6 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.7 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.8 Japan
8.4.8.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.8.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.8.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.8.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.8.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.9 China
8.4.9.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.9.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.9.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.9.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.9.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.10 India
8.4.10.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.10.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.10.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.10.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.10.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.11 Australia
8.4.11.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.11.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.11.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.11.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.11.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.12 Korea
8.4.12.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.12.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.12.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.12.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.12.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.13 Singapore
8.4.13.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.13.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.13.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.13.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.13.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.14 Hong Kong
8.4.14.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.14.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.14.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.14.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.14.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.15 Taiwan
8.4.15.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.15.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.15.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.15.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.15.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.16 Indonesia
8.4.16.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.16.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.16.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.16.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.16.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.17 Cambodia
8.4.17.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.17.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.17.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.17.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.17.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.18 Philippines
8.4.18.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.18.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.18.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.18.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.18.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.19 Vietnam
8.4.19.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.19.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.19.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.19.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.19.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.20 Malaysia
8.4.20.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.20.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.20.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.20.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.20.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.4.21 Thailand
8.4.21.1 Market size, by product, 2017 – 2030 (USD Million)
8.4.21.2 Market size, by product, 2017 – 2030 (000’ Units)
8.4.21.3 Market size, by process, 2017 – 2030 (USD Million)
8.4.21.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.4.21.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2017 – 2030 (USD Million)
8.5.2 Market size, by country, 2017 – 2030 (000’ Units)
8.5.3 Market size, by product, 2017 – 2030 (USD Million)
8.5.4 Market size, by product, 2017 – 2030 (000’ Units)
8.5.5 Market size, by process, 2017 – 2030 (USD Million)
8.5.6 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.5.7 Market size, by end-use, 2017 – 2030 (USD Million)
8.5.8 Brazil
8.5.8.1 Market size, by product, 2017 – 2030 (USD Million)
8.5.8.2 Market size, by product, 2017 – 2030 (000’ Units)
8.5.8.3 Market size, by process, 2017 – 2030 (USD Million)
8.5.8.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.5.8.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.5.9 Mexico
8.5.9.1 Market size, by product, 2017 – 2030 (USD Million)
8.5.9.2 Market size, by product, 2017 – 2030 (000’ Units)
8.5.9.3 Market size, by process, 2017 – 2030 (USD Million)
8.5.9.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.5.9.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.5.10 Argentina
8.5.10.1 Market size, by product, 2017 – 2030 (USD Million)
8.5.10.2 Market size, by product, 2017 – 2030 (000’ Units)
8.5.10.3 Market size, by process, 2017 – 2030 (USD Million)
8.5.10.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.5.10.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.6 MEA
8.6.1 Market size, by country, 2017 – 2030 (USD Million)
8.6.2 Market size, by country, 2017 – 2030 (000’ Units)
8.6.3 Market size, by product, 2017 – 2030 (USD Million)
8.6.4 Market size, by product, 2017 – 2030 (000’ Units)
8.6.5 Market size, by process, 2017 – 2030 (USD Million)
8.6.6 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.6.7 Market size, by end-use, 2017 – 2030 (USD Million)
8.6.8 Saudi Arabia
8.6.8.1 Market size, by product, 2017 – 2030 (USD Million)
8.6.8.2 Market size, by product, 2017 – 2030 (000’ Units)
8.6.8.3 Market size, by process, 2017 – 2030 (USD Million)
8.6.8.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.6.8.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.6.9 UAE
8.6.9.1 Market size, by product, 2017 – 2030 (USD Million)
8.6.9.2 Market size, by product, 2017 – 2030 (000’ Units)
8.6.9.3 Market size, by process, 2017 – 2030 (USD Million)
8.6.9.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.6.9.5 Market size, by end-use, 2017 – 2030 (USD Million)
8.6.10 South Africa
8.6.10.1 Market size, by product, 2017 – 2030 (USD Million)
8.6.10.2 Market size, by product, 2017 – 2030 (000’ Units)
8.6.10.3 Market size, by process, 2017 – 2030 (USD Million)
8.6.10.4 Market size, by therapeutic application, 2017 – 2030 (USD Million)
8.6.10.5 Market size, by end-use, 2017 – 2030 (USD Million)
Chapter 9 Company Profiles
9.1 Strategy dashboard, 2021
9.2 Asahi Intecc CO., LTD.
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Integer Holdings Corporation
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Johnson & Johnson Services, Inc.
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Kaneka Medix Corp.
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 SWOT analysis
9.6 Medtronic
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 MicroPort Scientific Corporation
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 Penumbra, Inc.
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Stryker
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Terumo Corporation
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Merit Medical Systems
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis